BindingDB logo
myBDB logout

Patent code US10202412

Compile Data Set for Download or QSAR
Found 19 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Matrix M2-1


(Human respiratory syncytial virus A (strain A2))
BDBM347274
PNG
(US10202412, Compound B)
Show SMILES CC(C)OC(=O)[C@H](C)NP(=O)(OC[C@@]1(C)O[C@H]([C@H](F)[C@@H]1O)n1cnc2c(nc(N)nc12)N(C)C)Oc1ccccc1
Show InChI InChI=1S/C25H35FN7O7P/c1-14(2)38-23(35)15(3)31-41(36,40-16-10-8-7-9-11-16)37-12-25(4)19(34)17(26)22(39-25)33-13-28-18-20(32(5)6)29-24(27)30-21(18)33/h7-11,13-15,17,19,22,34H,12H2,1-6H3,(H,31,36)(H2,27,29,30)/t15-,17+,19-,22+,25+,41?/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<1.68E+5n/an/an/an/a



Atea Pharmaceuticals, Inc.

US Patent


Assay Description
Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...


US Patent US10202412 (2019)

More data for this
Ligand-Target Pair
Matrix M2-1


(Human respiratory syncytial virus A (strain A2))
BDBM347288
PNG
(US10202412, Compound D)
Show SMILES CNc1nc(N)nc2n(cnc12)[C@@H]1O[C@](C)(COP(=O)(N[C@@H](C)C(=O)OC(C)C)Oc2ccccc2)[C@@H](O)[C@H]1F
Show InChI InChI=1S/C24H33FN7O7P/c1-13(2)37-22(34)14(3)31-40(35,39-15-9-7-6-8-10-15)36-11-24(4)18(33)16(25)21(38-24)32-12-28-17-19(27-5)29-23(26)30-20(17)32/h6-10,12-14,16,18,21,33H,11H2,1-5H3,(H,31,35)(H3,26,27,29,30)/t14-,16+,18-,21+,24+,40?/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+5n/an/an/an/a



Atea Pharmaceuticals, Inc.

US Patent


Assay Description
Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...


US Patent US10202412 (2019)

More data for this
Ligand-Target Pair
Matrix M2-1


(Human respiratory syncytial virus A (strain A2))
BDBM347275
PNG
(US10202412, Compound K)
Show SMILES CN(C)c1nc(N)nc2n(cnc12)[C@@H]1O[C@@](CO)(CCl)[C@@H](O)[C@H]1F
Show InChI InChI=1S/C13H18ClFN6O3/c1-20(2)9-7-10(19-12(16)18-9)21(5-17-7)11-6(15)8(23)13(3-14,4-22)24-11/h5-6,8,11,22-23H,3-4H2,1-2H3,(H2,16,18,19)/t6-,8+,11-,13-/m1/s1
PDB

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>2.25E+5n/an/an/an/a



Atea Pharmaceuticals, Inc.

US Patent


Assay Description
Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...


US Patent US10202412 (2019)

More data for this
Ligand-Target Pair
Matrix M2-1


(Human respiratory syncytial virus A (strain A2))
BDBM347282
PNG
(US10202412, Compound V)
Show SMILES CC[C@]1(COP(=O)(N[C@@H](C)C(=O)OC(C)C)Oc2ccccc2)O[C@H]([C@@H](F)[C@@H]1O)n1cnc2c(nc(N)nc12)N(C)C
Show InChI InChI=1S/C26H37FN7O7P/c1-7-26(13-38-42(37,41-17-11-9-8-10-12-17)32-16(4)24(36)39-15(2)3)20(35)18(27)23(40-26)34-14-29-19-21(33(5)6)30-25(28)31-22(19)34/h8-12,14-16,18,20,23,35H,7,13H2,1-6H3,(H,32,37)(H2,28,30,31)/t16-,18-,20-,23+,26+,42?/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.64E+5n/an/an/an/a



Atea Pharmaceuticals, Inc.

US Patent


Assay Description
Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...


US Patent US10202412 (2019)

More data for this
Ligand-Target Pair
Matrix M2-1


(Human respiratory syncytial virus A (strain A2))
BDBM347283
PNG
(US10202412, Compound W)
Show SMILES Nc1ccn([C@@H]2O[C@@](CO)(CCl)C(O)[C@H]2F)c(=O)n1
Show InChI InChI=1S/C10H13ClFN3O4/c11-3-10(4-16)7(17)6(12)8(19-10)15-2-1-5(13)14-9(15)18/h1-2,6-8,16-17H,3-4H2,(H2,13,14,18)/t6-,7?,8-,10-/m1/s1
PDB

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 9.60E+3n/an/an/an/a



Atea Pharmaceuticals, Inc.

US Patent


Assay Description
Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...


US Patent US10202412 (2019)

More data for this
Ligand-Target Pair
Matrix M2-1


(Human respiratory syncytial virus A (strain A2))
BDBM347278
PNG
(US10202412, Compound P)
Show SMILES CC[C@]1(COP(=O)(N[C@@H](C)C(=O)OC(C)C)Oc2ccccc2)O[C@H]([C@H](F)[C@@H]1O)n1cnc2c(nc(N)nc12)N(C)C
Show InChI InChI=1S/C26H37FN7O7P/c1-7-26(13-38-42(37,41-17-11-9-8-10-12-17)32-16(4)24(36)39-15(2)3)20(35)18(27)23(40-26)34-14-29-19-21(33(5)6)30-25(28)31-22(19)34/h8-12,14-16,18,20,23,35H,7,13H2,1-6H3,(H,32,37)(H2,28,30,31)/t16-,18+,20-,23+,26+,42?/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+5n/an/an/an/a



Atea Pharmaceuticals, Inc.

US Patent


Assay Description
Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...


US Patent US10202412 (2019)

More data for this
Ligand-Target Pair
Matrix M2-1


(Human respiratory syncytial virus A (strain A2))
BDBM347284
PNG
(US10202412, Compound X)
Show SMILES CC(C)C(=O)Nc1nc(N(C)C)c2ncn([C@@H]3O[C@@](CO)(CCl)[C@@H](O)[C@H]3F)c2n1
Show InChI InChI=1S/C17H24ClFN6O4/c1-8(2)14(28)23-16-21-12(24(3)4)10-13(22-16)25(7-20-10)15-9(19)11(27)17(5-18,6-26)29-15/h7-9,11,15,26-27H,5-6H2,1-4H3,(H,21,22,23,28)/t9-,11+,15-,17-/m1/s1
PDB

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>2.32E+5n/an/an/an/a



Atea Pharmaceuticals, Inc.

US Patent


Assay Description
Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...


US Patent US10202412 (2019)

More data for this
Ligand-Target Pair
Matrix M2-1


(Human respiratory syncytial virus A (strain A2))
BDBM347285
PNG
(US10202412, Compound Y)
Show SMILES CC(C)OC(=O)[C@H](C)NP(=O)(OC[C@@]1(CCl)O[C@H]([C@H](F)[C@@H]1O)n1cnc2c(nc(NC(=O)C(C)C)nc12)N(C)C)Oc1ccccc1
Show InChI InChI=1S/C29H40ClFN7O8P/c1-16(2)25(40)35-28-33-23(37(6)7)21-24(34-28)38(15-32-21)26-20(31)22(39)29(13-30,45-26)14-43-47(42,46-19-11-9-8-10-12-19)36-18(5)27(41)44-17(3)4/h8-12,15-18,20,22,26,39H,13-14H2,1-7H3,(H,36,42)(H,33,34,35,40)/t18-,20+,22-,26+,29+,47?/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.42E+5n/an/an/an/a



Atea Pharmaceuticals, Inc.

US Patent


Assay Description
Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...


US Patent US10202412 (2019)

More data for this
Ligand-Target Pair
Matrix M2-1


(Human respiratory syncytial virus A (strain A2))
BDBM347273
PNG
(US10202412, Compound A)
Show SMILES CN(C)c1nc(N)nc2n(cnc12)[C@@H]1O[C@](C)(CO)[C@@H](O)[C@H]1F
Show InChI InChI=1S/C13H19FN6O3/c1-13(4-21)8(22)6(14)11(23-13)20-5-16-7-9(19(2)3)17-12(15)18-10(7)20/h5-6,8,11,21-22H,4H2,1-3H3,(H2,15,17,18)/t6-,8+,11-,13-/m1/s1
PDB

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>3.06E+5n/an/an/an/a



Atea Pharmaceuticals, Inc.

US Patent


Assay Description
Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...


US Patent US10202412 (2019)

More data for this
Ligand-Target Pair
Matrix M2-1


(Human respiratory syncytial virus A (strain A2))
BDBM347278
PNG
(US10202412, Compound P)
Show SMILES CC[C@]1(COP(=O)(N[C@@H](C)C(=O)OC(C)C)Oc2ccccc2)O[C@H]([C@H](F)[C@@H]1O)n1cnc2c(nc(N)nc12)N(C)C
Show InChI InChI=1S/C26H37FN7O7P/c1-7-26(13-38-42(37,41-17-11-9-8-10-12-17)32-16(4)24(36)39-15(2)3)20(35)18(27)23(40-26)34-14-29-19-21(33(5)6)30-25(28)31-22(19)34/h8-12,14-16,18,20,23,35H,7,13H2,1-6H3,(H,32,37)(H2,28,30,31)/t16-,18+,20-,23+,26+,42?/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.64E+5n/an/an/an/a



Atea Pharmaceuticals, Inc.

US Patent


Assay Description
Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...


US Patent US10202412 (2019)

More data for this
Ligand-Target Pair
Matrix M2-1


(Human respiratory syncytial virus A (strain A2))
BDBM347281
PNG
(US10202412, Compound U)
Show SMILES CC[C@]1(CO)O[C@H]([C@@H](F)[C@@H]1O)n1cnc2c(nc(N)nc12)N(C)C
Show InChI InChI=1S/C14H21FN6O3/c1-4-14(5-22)9(23)7(15)12(24-14)21-6-17-8-10(20(2)3)18-13(16)19-11(8)21/h6-7,9,12,22-23H,4-5H2,1-3H3,(H2,16,18,19)/t7-,9-,12+,14+/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>2.94E+5n/an/an/an/a



Atea Pharmaceuticals, Inc.

US Patent


Assay Description
Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...


US Patent US10202412 (2019)

More data for this
Ligand-Target Pair
Matrix M2-1


(Human respiratory syncytial virus A (strain A2))
BDBM347286
PNG
(US10202412, Compound Z)
Show SMILES CC(C)OC(=O)[C@H](C)NP(=O)(OC[C@@]1(CCl)O[C@H]([C@H](F)C1O)n1ccc(N)nc1=O)Oc1ccccc1
Show InChI InChI=1S/C22H29ClFN4O8P/c1-13(2)34-20(30)14(3)27-37(32,36-15-7-5-4-6-8-15)33-12-22(11-23)18(29)17(24)19(35-22)28-10-9-16(25)26-21(28)31/h4-10,13-14,17-19,29H,11-12H2,1-3H3,(H,27,32)(H2,25,26,31)/t14-,17+,18?,19+,22+,37?/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.77E+5n/an/an/an/a



Atea Pharmaceuticals, Inc.

US Patent


Assay Description
Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...


US Patent US10202412 (2019)

More data for this
Ligand-Target Pair
Matrix M2-1


(Human respiratory syncytial virus A (strain A2))
BDBM347277
PNG
(US10202412, Compound O)
Show SMILES CC[C@]1(CO)O[C@H]([C@H](F)[C@@H]1O)n1cnc2c(nc(N)nc12)N(C)C
Show InChI InChI=1S/C14H21FN6O3/c1-4-14(5-22)9(23)7(15)12(24-14)21-6-17-8-10(20(2)3)18-13(16)19-11(8)21/h6-7,9,12,22-23H,4-5H2,1-3H3,(H2,16,18,19)/t7-,9+,12-,14-/m1/s1
PDB

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+5n/an/an/an/a



Atea Pharmaceuticals, Inc.

US Patent


Assay Description
Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...


US Patent US10202412 (2019)

More data for this
Ligand-Target Pair
Matrix M2-1


(Human respiratory syncytial virus A (strain A2))
BDBM347276
PNG
(US10202412, Compound L)
Show SMILES CC(C)OC(=O)[C@H](C)NP(=O)(OC[C@@]1(CCl)O[C@H]([C@H](F)[C@@H]1O)n1cnc2c(nc(N)nc12)N(C)C)Oc1ccccc1
Show InChI InChI=1S/C25H34ClFN7O7P/c1-14(2)39-23(36)15(3)32-42(37,41-16-9-7-6-8-10-16)38-12-25(11-26)19(35)17(27)22(40-25)34-13-29-18-20(33(4)5)30-24(28)31-21(18)34/h6-10,13-15,17,19,22,35H,11-12H2,1-5H3,(H,32,37)(H2,28,30,31)/t15-,17+,19-,22+,25+,42?/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.59E+5n/an/an/an/a



Atea Pharmaceuticals, Inc.

US Patent


Assay Description
Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...


US Patent US10202412 (2019)

More data for this
Ligand-Target Pair
Matrix M2-1


(Human respiratory syncytial virus A (strain A2))
BDBM347277
PNG
(US10202412, Compound O)
Show SMILES CC[C@]1(CO)O[C@H]([C@H](F)[C@@H]1O)n1cnc2c(nc(N)nc12)N(C)C
Show InChI InChI=1S/C14H21FN6O3/c1-4-14(5-22)9(23)7(15)12(24-14)21-6-17-8-10(20(2)3)18-13(16)19-11(8)21/h6-7,9,12,22-23H,4-5H2,1-3H3,(H2,16,18,19)/t7-,9+,12-,14-/m1/s1
PDB

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>2.93E+5n/an/an/an/a



Atea Pharmaceuticals, Inc.

US Patent


Assay Description
Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...


US Patent US10202412 (2019)

More data for this
Ligand-Target Pair
Matrix M2-1


(Human respiratory syncytial virus A (strain A2))
BDBM347279
PNG
(US10202412, Compound S)
Show SMILES CN(C)c1nc(N)nc2n(cnc12)[C@@H]1O[C@](C)(CO)[C@@H](O)[C@@H]1F
Show InChI InChI=1S/C13H19FN6O3/c1-13(4-21)8(22)6(14)11(23-13)20-5-16-7-9(19(2)3)17-12(15)18-10(7)20/h5-6,8,11,21-22H,4H2,1-3H3,(H2,15,17,18)/t6-,8-,11+,13+/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>3.06E+5n/an/an/an/a



Atea Pharmaceuticals, Inc.

US Patent


Assay Description
Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...


US Patent US10202412 (2019)

More data for this
Ligand-Target Pair
Matrix M2-1


(Human respiratory syncytial virus A (strain A2))
BDBM347280
PNG
(US10202412, Compound T)
Show SMILES CC(C)OC(=O)[C@H](C)NP(=O)(OC[C@@]1(C)O[C@H]([C@@H](F)[C@@H]1O)n1cnc2c(nc(N)nc12)N(C)C)Oc1ccccc1
Show InChI InChI=1S/C25H35FN7O7P/c1-14(2)38-23(35)15(3)31-41(36,40-16-10-8-7-9-11-16)37-12-25(4)19(34)17(26)22(39-25)33-13-28-18-20(32(5)6)29-24(27)30-21(18)33/h7-11,13-15,17,19,22,34H,12H2,1-6H3,(H,31,36)(H2,27,29,30)/t15-,17-,19-,22+,25+,41?/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.67E+5n/an/an/an/a



Atea Pharmaceuticals, Inc.

US Patent


Assay Description
Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...


US Patent US10202412 (2019)

More data for this
Ligand-Target Pair
Matrix M2-1


(Human respiratory syncytial virus A (strain A2))
BDBM347287
PNG
(US10202412, Compound C)
Show SMILES CNc1nc(N)nc2n(cnc12)[C@@H]1O[C@](C)(CO)[C@@H](O)[C@H]1F
Show InChI InChI=1S/C12H17FN6O3/c1-12(3-20)7(21)5(13)10(22-12)19-4-16-6-8(15-2)17-11(14)18-9(6)19/h4-5,7,10,20-21H,3H2,1-2H3,(H3,14,15,17,18)/t5-,7+,10-,12-/m1/s1
PDB

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+5n/an/an/an/a



Atea Pharmaceuticals, Inc.

US Patent


Assay Description
Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...


US Patent US10202412 (2019)

More data for this
Ligand-Target Pair
Matrix M2-1


(Human respiratory syncytial virus A (strain A2))
BDBM347283
PNG
(US10202412, Compound W)
Show SMILES Nc1ccn([C@@H]2O[C@@](CO)(CCl)C(O)[C@H]2F)c(=O)n1
Show InChI InChI=1S/C10H13ClFN3O4/c11-3-10(4-16)7(17)6(12)8(19-10)15-2-1-5(13)14-9(15)18/h1-2,6-8,16-17H,3-4H2,(H2,13,14,18)/t6-,7?,8-,10-/m1/s1
PDB

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 600n/an/an/an/a



Atea Pharmaceuticals, Inc.

US Patent


Assay Description
Test compounds were dissolved in DMSO and then prepared in eight half-log dilutions in MEM medium with 50 μg/mL gentamicin and 2% FBS (MA-104 ce...


US Patent US10202412 (2019)

More data for this
Ligand-Target Pair
* indicates data uncertainty>20%